Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 2, 2004, Pages 246-249

  Brenneis, C ^a   Seppi, K ^a   Schocke, M ^a   Benke, T ^a   Wenning, G K ^a   Poewe, W ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATROPHY; BRAIN ATROPHY; BRAIN REGION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FRONTAL LOBE; GRAY MATTER; HUMAN; INSULA; MESENCEPHALON; METHODOLOGY; MORPHOMETRICS; MOTOR CORTEX; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; STATISTICAL SIGNIFICANCE; STRIATE CORTEX; TEMPORAL LOBE; VOLUMETRY; WHITE MATTER;

ATROPHY; COGNITION DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; FRONTAL LOBE; HUMANS; NEUROPSYCHOLOGICAL TESTS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0842309207     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Burn D, Lees A. Progressive supranuclear palsy: where are we now? Lancet Neurol 2003;1:359.
2. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19.
3. Doniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-70.
4. Verny M, Jellinger KA, Hauw JJ, et al. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol (Berl) 1996;91:427-31.
5. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-20.
6. Santocruz P, Uttl B, Litvan I, et al. Progressive supranuclear palsy: a survey of the disease course. Neurology 1998;50:1637-47.
7. Pillon B, Dubois B. Cognitive and behavioral impairments. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical research approaches. New York: Oxford University Press, 1992.
8. Maher ER, Smith EM, Lees AJ. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 1985;48:1234-9.
9. Cambier J, Masson M, Viader F, et al. Frontal syndrome of progressive supranuclear palsy. Rev Neurol (Paris) 1985;141:528-36. [In French].
10. Pillon B, Gouider-Khouja N, Deweer B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995;58:174-9.
11. Grafman J, Litvan I, Gomez C, et al. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990;47:553-8.
12. Pillon B, Dubais B, Ploska A, et al. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991;41:634-43.
13. Jellinger KA, Bancher C, Hauw JJ, et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;59:106.
14. Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998;8:387-402.
15. Foster NL, Gilman S, Berent S, et al. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 1988;24:399-406.
16. Goffinet AM, De Volder AG, Gillain C, et al. Positron tomography demonstrates frontal lobe hypametabolism in progressive supranuclear palsy. Ann Neurol 1989;25:131-9.
17. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-84.
18. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999;7:254-66.
19. Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage 2001;14:1238-43.
20. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21-36.
21. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-21.
22. Asato R, Akiguchi I, Masunaga S, et al. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. J Neurol Transm 2000;107:1427-36.
23. Warmuth-Metz M, Naumann M, Csoti I, et al. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001;58:1076-9.
24. Jellinger K, Brancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical research approaches. New York: Oxford University Press, 1992.
25. Hof PR, Delacourte A, Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 1992;84:45-51.
26. Hanihara T, Amano N, Takahashi T, et al. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 1995;21:319-26.
27. Verny M, Duyckaerts C, Agid Y, et al. The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 1996;119:1123-36.
28. Cordato NJ, Pantelis C, Halliday GM, et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 2002;125:789-800.
29. Johnson KA, Sperling RA, Holman BL, et al. Cerebral perfusion in progressive supranuclear palsy. J Nucl Med 1992;33:704-9.
30. Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997;120:1541-52.
31. Abe K, Terakawa H, Takanashi M, et al. Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 2000;52:589-95.
32. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994;6:358-70.
33. Litvan I, Mega MS, Cummings JL, et al. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47:1184-9.
34. Pillon B, Deweer B, Michon A, et al. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology 1994;44:1264-70.
35. Litvan I. Progressive supranuclear palsy revisited. Acta Neurol Scand 1998;98:73-84.
36. Bak T, Hodges JR. The neuropsychology of progressive supranuclear palsy. Neurocase 1998;4:89-94.
37. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-52.
38. Rombouts SA, Barkhof F, Witter MP, et al. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-3.
39. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-68.
40. Van Hoesen GW, Parvizi J, Chu CC. Orbitofrontal cortex pathology in Alzheimer's disease. Cereb Cortex 2000;10:243-51.
41. Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001;14:298-309.
42. Petit L, Haxby JV. Functional anatomy of pursuit eye movements in humans as revealed by fMRI. J Neurophysiol 1999;82:463-71.
43. Leigh RJ, Zee DS. The neurology of eye movements. New York: Oxford University Press, 1999.
44. O'Driscoll GA, Wolff AL, Benkelfat C, et al. Functional neuroanatomy of smooth pursuit and predictive saccades. Neuroreport 2000;11:1335-40.
45. Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65-74.